Novo Nordisk CEO explains why new GLP-1 pill expands access to the weight loss drugs
- Posted on January 12, 2026
- By CNBC
- 5 Views
Novo Nordisk CEO explains why new GLP-1 pill expands access to the weight loss drugs
Novo Nordisk CEO Mike Doustdar told Jim Cramer about developments in obesity treatment.
